Drug recall · December 22, 2021
Lidocaine Hydrochloride Topical Solution USP 4% recall
Why: CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Manufactured by: Teligent Pharma Inc., Buena, NJ 06310, Distributed by: McKesson Corporation dba Sky Packaging, 497 Southridge Blvd, Suite 101, Memphis, TN 36141, NDC 63739-997-64.
- Lots / codes
Lot #: 16306, Exp. Date 01/2024.
- Quantity
- 7,008 glass bottles
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Nationwide within the United States
- Initiated
- October 12, 2021 · Voluntary: Firm initiated
- Classified
- December 13, 2021
- Reported
- December 22, 2021
- Ended
- June 18, 2024
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.